Cite
Misaghian-Xanthos N, Shariff AI, Mekala K, et al. Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions. Diabetes Care. 2017;40(6):e65-e66doi: 10.2337/dc16-2591.
Misaghian-Xanthos, N., Shariff, A. I., Mekala, K., Fearrington, L. R., Setji, T. L., Aloi, J. A., & Buse, J. B. (2017). Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions. Diabetes care, 40(6), e65-e66. https://doi.org/10.2337/dc16-2591
Misaghian-Xanthos, Negin, et al. "Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions." Diabetes care vol. 40,6 (2017): e65-e66. doi: https://doi.org/10.2337/dc16-2591
Misaghian-Xanthos N, Shariff AI, Mekala K, Fearrington LR, Setji TL, Aloi JA, Buse JB. Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions. Diabetes Care. 2017 Jun;40(6):e65-e66. doi: 10.2337/dc16-2591. Epub 2017 Mar 28. PMID: 28351898; PMCID: PMC5439416.
Copy
Download .nbib